As shelter-in-place orders drag on and the U.S. economy limps through the second quarter, investors, economists and politicians are asking important questions about what the post-outbreak economy will look like and how quickly the U.S. can replace the 26 million jobs it has lost in 2020.
Many Americans have been turning to cannabis to help them get through the stress of the COVID-19 outbreak, but there’s a strong case that U.S. marijuana legalization could help the economy recover as well.
Throughout the downturn, states like Michigan and California have deemed cannabis an “essential” product not subject to mandatory shutdowns. In fact, cannabis sales have skyrocketed in many of those locations.
Yet these businesses deemed to be essential by local and state governments are still illegal on a federal level. On Tuesday, DataTrek Research co-founder Jessica Rabe said the cannabis industry has several unique characteristics that could be extremely beneficial to an economy trying to get back on its feet.
In states in which marijuana is decriminalized, the industry has provided a job boom. For example, there are now as many cannabis workers in Nevada as there are bartenders, according to Leafly. Massachusetts has more cannabis workers than hair stylists and cosmetologists.
Economics Of Cannabis
Rabe estimates that legalizing marijuana on a federal level could add 170,000 jobs in the states of New York and New Jersey alone.
At the same time, many of these jobs are relatively high-paying and do not require even a college degree, she said. According to Glassdoor, the median salary for a legal marijuana job in the U.S. in January 2019 was $58,500.
Rabe said she wouldn’t be surprised to see more politicians turn to cannabis as the U.S. recovers from the outbreak.
“Legalizing sales of recreational marijuana could add tens of thousands of high paying, quality jobs at all education levels in states across the US. Aside from tax revenue, this is another reason large US states like New York that have been deeply affected by the virus may try to speed up legalization,” she said.
Benzinga’s Take
One way for investors to play the boom in cannabis demand in legalized states and a potential outcry for U.S. federal legalization heading into the 2020 election is to buy U.S. multistate operators.
Earlier this month, Alan Brochstein, author of the 420 Investor and founding partner of New Cannabis Ventures, told Benzinga that MSOs Cresco Labs Inc CRLBF, Curaleaf Holdings Inc CURLF, Green Thumb Industries Inc GTBIF and Trulieve Cannabis Corp TCNNF are the safest bets for cannabis investors in the current environment.
Do you agree with this take? Email feedback@benzinga.com with your thoughts.
Related Links:
Cannabis Stock Rally Puts Short Sellers In The Red For 2020
These 4 Cannabis Stocks Are The Safest Bets Right Now, Expert Says
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.